According to Ironwood Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.7248. At the end of 2024 the company had a P/S ratio of 1.70.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.70 | -57.94% |
2023 | 4.03 | -12.84% |
2022 | 4.63 | 0.37% |
2021 | 4.61 | -1.49% |
2020 | 4.68 | -4.35% |
2019 | 4.89 | 6.05% |
2018 | 4.61 | -32.17% |
2017 | 6.80 | -7.05% |
2016 | 7.32 | -25.84% |
2015 | 9.87 | -60.57% |
2014 | 25.0 | -52% |
2013 | 52.2 | 803.9% |
2012 | 5.77 | -46.96% |
2011 | 10.9 | -4.35% |
2010 | 11.4 |